COMPARE · Data as of August 28, 2026
FUTU vs HOOD
Verdict: Side-by-side breakdown using the Bull Rankings model. FUTU scored 81.0, HOOD scored 77.0 — FUTU leads.
Compare another set
FUTU
Futu Holdings Limited
65.9Fin
$124.26 · $17.4B
Strength gap
12.7
FUTU leads
HOOD
Robinhood Markets, Inc.
53.2Fin
$109.76 · $98.7B
fundamentals as of
At a glance · who leads each dimension, on the model's own rules
- CheapestFUTU12.4x
Side by side · every name on one set of axes
Fundamentals, head-to-head
FUTU
HOOD
—
Rev
+51.6%A
12.4xB+
P/E
48.1xD
30.5%A
ROE
23.6%A-
3.48C
P/B
10.41D
2.1%B
Yield
0.0%C
Winner per row is the stronger grade; where grades tie, the better figure breaks it. A true tie or a missing value shows no highlight.
The companies
FUTUFutu Holdings Limited
Why now
Capital Markets · market cap $17.4b. Down 39% from 52-week high of $202.53 — deep drawdown territory. PEG 0.59 — paying under fair value for the growth rate. 18 sell-side analysts rate this a Strong Buy with a mean 1-yr target of $161.00 (implying +30% upside).
Moat
Net margin 46% is exceptional — pricing-power territory rare outside premium software, branded staples, and specialty pharma. ROE 31% — top-decile capital efficiency. Either pricing leverage, low capital intensity, or aggressive buybacks; the durability story depends on which. Financial moat — scale of deposit base / underwriting franchise plus regulatory capital advantages. The largest players compound book value through cycles that erase smaller competitors.
Risk
Down 39% from the 52-week high — the market is pricing in something the screen can't see; verify the bear case before sizing up. Duration mismatch — the asset and liability books reprice on different schedules; a rapid move in rates either direction can compress net interest margin before management can reposition.
HOODRobinhood Markets, Inc.
Why now
Capital Markets · market cap $98.7b. Down 29% from 52-week high of $153.86 — deep drawdown territory. Revenue growing +52% — in hypergrowth territory. 26 sell-side analysts rate this a Buy with a mean 1-yr target of $120.08 (implying +9% upside).
Moat
Net margin 42% is exceptional — pricing-power territory rare outside premium software, branded staples, and specialty pharma. ROE 24% sits above Buffett's preferred 15% threshold — the equity base is compounding at a rate the market struggles to discount accurately. $98.7b market cap gives the company enough scale to absorb fixed costs that subscale competitors can't, without yet being so large that growth has to come from acquisition.
Risk
D/E 2.40 is elevated — limits strategic flexibility and raises refinancing exposure if rates stay higher for longer. Beta 2.32 implies above-market volatility — position-size to the drawdowns this name will produce in a market correction, not to its bull-case return. Trailing P/E 48x sits well above the S&P median (~20x) — multiple compression is a real risk if revenue growth decelerates.
Verdict — model-derived comparison
Generating verdict… typically 5–10 seconds
Not investment advice. The Bull Rankings publishes a quantitative ranking model and accompanying analysis for general informational purposes only. Nothing on this page is a recommendation to buy, sell, or hold any security; nothing is personalized to your circumstances, risk tolerance, or tax situation. Investing carries the risk of loss — invest at your own risk and consider consulting a licensed financial professional before acting on anything you read here. See terms and methodology for full disclosures.